Prothena Corporation plc [PRTA] stock is trading at $14.98, up 7.69%. An important factor to consider is whether the stock is rising or falling in short-term value. The PRTA shares have gain 8.63% over the last week, with a monthly amount glided 8.79%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Prothena Corporation plc [NASDAQ: PRTA] stock has seen the most recent analyst activity on December 20, 2024, when Chardan Capital Markets initiated its Buy rating and assigned the stock a price target of $40. Previously, BofA Securities downgraded its rating to Neutral on January 30, 2024, and dropped its price target to $38. On December 12, 2023, Deutsche Bank initiated with a Buy rating and assigned a price target of $62 on the stock. SVB Securities started tracking the stock assigning a Outperform rating and suggested a price target of $80 on April 24, 2023. Piper Sandler initiated its recommendation with a Overweight and recommended $94 as its price target on January 27, 2023. RBC Capital Mkts downgraded its rating to Sector Perform for this stock on November 04, 2022, and upped its price target to $55. In a note dated September 28, 2022, BofA Securities upgraded an Buy rating on this stock.
Prothena Corporation plc [PRTA] stock has fluctuated between $11.70 and $31.03 over the past year. Currently, Wall Street analysts expect the stock to reach $58.5 within the next 12 months. Prothena Corporation plc [NASDAQ: PRTA] shares were valued at $14.98 at the most recent close of the market. An investor can expect a potential return of 290.52% based on the average PRTA price forecast.
Analyzing the PRTA fundamentals
Prothena Corporation plc [NASDAQ:PRTA] reported sales of 133.35M for the trailing twelve months, which represents a drop of -98.86%. Gross Profit Margin for this corporation currently stands at 0.45% with Operating Profit Margin at -1.26%, Pretax Profit Margin comes in at -1.05%, and Net Profit Margin reading is -0.99%. To continue investigating profitability, this company’s Return on Assets is posted at -0.22, Equity is -0.24 and Total Capital is -0.31. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 14.09 points at the first support level, and at 13.20 for the second support level. However, for the 1st resistance point, the stock is sitting at 15.47, and for the 2nd resistance point, it is at 15.97.
Ratios To Look Out For
For context, Prothena Corporation plc’s Current Ratio is 11.52. On the other hand, the Quick Ratio is 11.52, and the Cash Ratio is 11.19. Considering the valuation of this stock, the price to sales ratio is 6.04, the price to book ratio is 1.51.
